Different Biodistribution of 99mTc-labelled Chimeric Mouse-human Monoclonal Antibody Between Athymic Mice Model and Human

Overview

Journal Br J Cancer

Specialty Oncology

Date 1996 Jun 1

PMID 8664114

Citations 1

Authors

N Oriuchi

N Watanabe

S Sugiyama

T Higuchi

K Imai

H Yamanaka

M Hashimoto

H Kanda

K Endo

Affiliations

Soon will be listed here.

Abstract

Biodistribution of chimeric mouse/human monoclonal antibody against non-specific cross-reacting antigen (chNCA Ab) was studied in athymic mice and patients with metastatic bone disease. 99mTc-chNCA Ab showed a high labelling efficiency, stability and also a high binding ratio to human granulocytes. Since NCA showed cross-reactivity with carcinoembryonic antigen (CEA), animal experiments showed that 99mTc-chNCA Ab was accumulated in the xenografted tumour which expressed CEA, suggesting the preserved immunoreactivity of labelled materials. In the clinical study, injected 99mTc-chNCA Ab formed a high molecular weight complex immediately after intravenous administration and was trapped mainly in liver. The first-phase plasma half-life was 6.4 +/- 1.1 min. None of the patients showed adverse reaction or human antimurine or anti-chimeric antibody in their serum. 99mTc-chNCA Ab demonstrated remarkably different biodistribution between patients and the animal model and showed different pharmacokinetics from other murine and chimeric Abs reported previously. For safety HPLC analysis should be performed before clinical radioimmunodetection or radioimmunotherapy by incubating radiolabelled MAb with human serum under strict conditions.

Citing Articles

Monoclonal antibody A7 coupled to magnetic particles as a contrast enhancing agent for magnetic resonance imaging of human colorectal carcinoma.

Otsuji E, Kuriu Y, Okamoto K, Ichikawa D, Hagiwara A, Ito H Cancer Immunol Immunother. 2005; 55(6):728-33.

PMID: 16273351 PMC: 11030920. DOI: 10.1007/s00262-005-0067-9.

References

Bosslet K, Luben G, Schwarz A, Hundt E, Harthus H, Seiler F . Immunohistochemical localization and molecular characteristics of three monoclonal antibody-defined epitopes detectable on carcinoembryonic antigen (CEA). Int J Cancer. 1985; 36(1):75-84. DOI: 10.1002/ijc.2910360113. View

Baum R, Hertel A, Lorenz M, Schwarz A, Encke A, Hor G . 99Tcm-labelled anti-CEA monoclonal antibody for tumour immunoscintigraphy: first clinical results. Nucl Med Commun. 1989; 10(5):345-52. DOI: 10.1097/00006231-198905000-00005. View

Potter H, Weir L, Leder P . Enhancer-dependent expression of human kappa immunoglobulin genes introduced into mouse pre-B lymphocytes by electroporation. Proc Natl Acad Sci U S A. 1984; 81(22):7161-5. PMC: 392097. DOI: 10.1073/pnas.81.22.7161. View

von Kleist S, Chavanel G, Burtin P . Identification of an antigen from normal human tissue that crossreacts with the carcinoembryonic antigen. Proc Natl Acad Sci U S A. 1972; 69(9):2492-4. PMC: 426972. DOI: 10.1073/pnas.69.9.2492. View

Shawler D, Bartholomew R, Smith L, Dillman R . Human immune response to multiple injections of murine monoclonal IgG. J Immunol. 1985; 135(2):1530-5. View

Ledermann J, Marston N, Stahel R, Waibel R, Buscombe J, Ell P . Biodistribution and tumour localisation of 131I SWA11 recognising the cluster w4 antigen in patients with small cell lung cancer. Br J Cancer. 1993; 68(1):119-21. PMC: 1968318. DOI: 10.1038/bjc.1993.297. View

Primus F, Bennett S, Kim E, DeLand F, Zahn M, Goldenberg D . Circulating immune complexes in cancer patients receiving goat radiolocalizing antibodies to carcinoembryonic antigen. Cancer Res. 1980; 40(3):497-501. View

Goldenberg D, Deland F, Kim E, Bennett S, Primus F, van Nagell Jr J . Use of radiolabeled antibodies to carcinoembryonic antigen for the detection and localization of diverse cancers by external photoscanning. N Engl J Med. 1978; 298(25):1384-6. DOI: 10.1056/NEJM197806222982503. View

Reuland P, Winker K, Heuchert T, Ruck P, Muller-Schauenburg W, Weller S . Detection of infection in postoperative orthopedic patients with technetium-99m-labeled monoclonal antibodies against granulocytes. J Nucl Med. 1991; 32(12):2209-14. View

10.

Mather S, Ellison D . Reduction-mediated technetium-99m labeling of monoclonal antibodies. J Nucl Med. 1990; 31(5):692-7. View

11.

Hunter W, GREENWOOD F . Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature. 1962; 194:495-6. DOI: 10.1038/194495a0. View

12.

Koga H, Kanda H, Nakashima M, Watanabe Y, Endo K, Watanabe T . Mouse-human chimeric monoclonal antibody to carcinoembryonic antigen (CEA): in vitro and in vivo activities. Hybridoma. 1990; 9(1):43-56. DOI: 10.1089/hyb.1990.9.43. View

13.

Watanabe N, Oriuchi N, Sugiyama S, Kuroki M, Matsuoka Y . Radioimmunoscintigraphy of colorectal cancer with technetium-99m-labeled murine anti-carcinoembryonic antigen monoclonal antibody in athymic nude mice. Ann Nucl Med. 1994; 8(1):23-30. DOI: 10.1007/BF03164983. View

14.

Davidson B, Babich J, Young H, Waddington W, Clarke G, Short M . The effect of circulating antigen and radiolabel stability on the biodistribution of an indium labelled antibody. Br J Cancer. 1991; 64(5):850-6. PMC: 1977445. DOI: 10.1038/bjc.1991.412. View

15.

Munz D, Sandrock D, Rilinger N . Comparison of immunoscintigraphy and colloid scintigraphy of bone marrow. Lancet. 1990; 336(8709):258-9. DOI: 10.1016/0140-6736(90)91794-b. View

16.

Mach J, Carrel S, Forni M, Ritschard J, Donath A, Alberto P . Tumor localization of radio-labeled antibodies against carcinoembryonic antigen in patients with carcinoma: a critical evaluation. N Engl J Med. 1980; 303(1):5-10. DOI: 10.1056/NEJM198007033030102. View

17.

Hnatowich D, Gionet M, Rusckowski M, Siebecker D, Roche J, Shealy D . Pharmacokinetics of 111In-labeled OC-125 antibody in cancer patients compared with the 19-9 antibody. Cancer Res. 1987; 47(22):6111-7. View

18.

Oriuchi N, Endo K, Watanabe N, Sugiyama S, Asao T, Takenoshita S . Semiquantitative SPECT tumor uptake of technetium-99m-labeled anti-CEA monoclonal antibody in colorectal tumor. J Nucl Med. 1995; 36(4):679-83. View

19.

Schroff R, Foon K, Beatty S, Oldham R, Morgan Jr A . Human anti-murine immunoglobulin responses in patients receiving monoclonal antibody therapy. Cancer Res. 1985; 45(2):879-85. View

20.

Boulianne G, Hozumi N, Shulman M . Production of functional chimaeric mouse/human antibody. Nature. 1984; 312(5995):643-6. DOI: 10.1038/312643a0. View